52. Reimer G, Rose KM, Scheer U, et al. Autoantibody to RNA polymerase I in scleroderma sera. J Clin Invest 1987;79:65–72.
53.
Kuwana M, Kaburaki J, Mimori T, et al. Autoantibody reactive with three
classes of RNA polymerases in sera from patients with systemic
sclerosis. J Clin Invest 1993;91:1399–404.
54. Fritzler MJ, von
Muhlen CA, Toffoli SM, et al. Autoantibodies to the nucleolar organizer
antigen NOR-90 in children with systemic rheumatic diseases. J Rheumatol
1995;22:521–4.
55. Fujii T, Mimori T, Akizuki M. Detection of
autoantibodies to nucleolar transcription factor nor 90/hUBF in sera of
patients with rheumatic diseases, by recombinant autoantigen-based
assays. Arthritis Rheum 1996;39:1313–8.
56. Imai H, Ochs RL,
Kiyosawa K, et al. Nucleolar antigens and autoantibodies in
hepatocellular carcinoma and other malignancies. Am J Pathol
1992;140:859–70.
57. Yamasaki Y, Honkanen-Scott M, Hernandez L, et
al. Nucleolar staining cannot be used as a screening test for the
scleroderma marker anti-RNA polymerase I/III antibodies. Arthritis Rheum
2006;54:3051–6.